Open Studies at Cetero Research – San Antonio, Texas
Type II Diabetes (C11-1880)
Watch our Type II Diabetes commercial!
Study Medication: Investigational Oral Medication or Placebo (Inactive Substance)
Inclusion Criteria: Type 2 Diabetic; Must currently be managing your diabetes with diet and exercise alone OR be taking up to 2 oral anti-diabetic medications
Study Length: 77 days, with 20 consecutive overnight stays and one follow-up phone call
Study Visit Dates: (tentative, but screening for this study will resume on Monday, February 20)
Gender: Male and Female
Ages: 18 to 68
BMI: 18-40 kg/m2
Compensation: up to $5,150 for time and travel
Study ID: C11-1880
Type II Diabetes (Metformin Only)
We are seeking type II diabetics who only take Metformin mediation for their diabetes. We have multiple research opportunities available that may meet your needs, such as overnight studies as well as outpatient studies.
If you are a first time study participant, we are here to answer any questions you may have about participating in a research trial.
Cetero Research will provide full attention to your inquiry, so please do not hesitate to register online or call us for more information.
Healthy Studies
Recruitment is currently under way, so call us to find out about our screening dates and additional inclusion/exclusion criteria for these healthy studies. Space is limited.
Call (210) 615-5579
Post-herpetic Neuralgia Study
If you suffer from this painful condition, Cetero Research will be conducting a clinical trial testing an investigational medication that has advantages in that it will be much more convenient than taking medications 3 or 4 times daily.
We would like to know if people, such as you, would be interested in participating in this study. Candidates must be diagnosed with Post-Herpetic Neuralgia to qualify. Email us at SATstudies@cetero.com or register online.
For information about this condition, you may click on the following link: http://bit.ly/x2SxL4
Low Testosterone (C11-1310)
Study Medication: Investigational Nasal Spray Medication
Inclusion Criteria: Male; Aged 18 – 80; Must have been diagnosed with low testosterone.
Compensation: Paid for time and travel
Type I Diabetes (SA1716)
Type II Diabetes (SA1707)
Nephropathy - Renal (SA1504)
A1c Testing
Attention diabetics:
How well are you controlling your blood sugars? Have you checked your A1c level within the last 3 months?
If not , then register online or call (210) 615-5552 to see if you qualify to receive this screening.
We now have a Facebook and Twitter page
Please “like” us on Facebook and follow us on Twitter. You will also be able to view studies as well as updates. Studies will still be posted here. You do not have to sign up for these networks if you do not want to.
Search for us on Facebook as Cetero Research San Antonio and on Twitter as CeteroSA.
Growth Hormone (SA1580)
Study Medication: Investigational injection medication or placebo
Gender: Males and Females
Age: 25 to 65
Compensation: call for details
Study ID: SA1580
Info: Call (210) 615-5579 for details
Note: To qualify, you must be diagnosed with growth hormone deficiency. This is not a healthy study.
